封面
市場調查報告書
商品編碼
1529896

伴同性動物保健市場規模、佔有率、趨勢分析報告:按動物、按產品、按分銷管道、按最終用途、按地區、細分市場預測,2024-2030 年

Companion Animal Health Market Size, Share & Trends Analysis Report By Animal (Dogs, Cats), By Product (Diagnostics, Pharmaceuticals), By Distribution Channel (E-commerce, Retail), By End-Use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

伴同性動物保健市場的成長與趨勢:

根據 Grand View Research, Inc. 的最新報告,到 2030 年,全球伴同性動物保健市場規模預計將達到 425 億美元,預測期內複合年成長率為 9.3%。

該市場的推動因素包括不斷增加的研究和開發計劃、越來越多的政府舉措、越來越多的寵物收養、大量的獸醫手術以及伴同性動物慢性疾病的流行,儘管經歷了許多挑戰,但獸醫仍然能夠工作。對美國、英國、法國和巴西 3000 多名寵物飼主的調查發現,自疫情爆發以來,超過四分之一的飼主由於擔心感染疾病而推遲或避免聯繫獸醫。

此外,大多數飼主(65%)表示,疫情並未對他們獲得藥物或治療產生負面影響。根據美國獸醫協會的數據,美國約有 70% 的家庭(9,050 萬戶)擁有寵物,其中狗和貓是最常見的品種。由於養寵物的人數不斷增加,對寵物藥品的需求不斷成長,也推動了市場的發展。對優質獸醫護理的需求不斷成長也推動了伴同性動物藥品市場的發展。過去十年,獸醫研究和開發活動穩步成長。寵物外科和專業醫學領域出現了許多創新。為了確立自己的市場領導者地位,領先的公司正在策略性地採用新技術。

例如,2022年1月,FDA核准了碩騰首個治療骨關節炎的單株抗體藥物Solensia。同樣,該公司也發布了 Librela,一種可減輕狗關節炎疼痛的單株抗體。近年來,在法國等國家,寵物疾病的盛行率上升,增加了對寵物治療的需求。肥胖、牙齒問題、皮膚過敏、骨關節炎和病毒性疾病是法國最常見的寵物疾病。法國寵物疾病盛行率的上升凸顯了對藥物和預防保健以維持寵物健康和快樂的需求。此外,藥品和疫苗需求的成長預計將進一步提振市場。確保動物用藥品安全的政府機構(例如法國動物用藥品管理局(ANMV))的存在正在促進市場的成長。

伴同性動物保健市場報告亮點

  • 從產品來看,2023年醫藥部門佔據壓倒性佔有率,超過44.43%。隨著寵物數量的顯著增加,有助於延長動物壽命的藥物的採用加速了。
  • 由於寵物醫療成本上升,特別是在新興市場,到 2023 年,狗類市場的佔有率將超過 40.0%。
  • 以分銷管道來看,醫院藥局業務佔最大佔有率,2023年將超過47%。寵物擁有量的增加增加了全球獸醫醫院和診所的可用性。
  • 到2023年,醫院和診所的最終用途部分將佔據壓倒性的佔有率,超過80%。這是因為擁有創新基礎設施的獸醫醫院和診所正在世界各地擴張。影響該細分市場成長的另一個方面是獸醫數量的增加。
  • 2023年北美佔總市佔率35.82%。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章伴同性動物保健市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 伴同性動物保健市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • 管道分析

第4章伴同性動物保健市場:動物、估計和趨勢分析

  • 全球伴同性動物保健市場:動物儀表板
  • 全球伴同性動物保健市場:動物變遷分析
  • 全球伴同性動物保健市場:依動物、按收益
  • 其他

第5章伴同性動物保健市場:產品、估計和趨勢分析

  • 全球伴同性動物保健市場:產品儀表板
  • 全球伴同性動物保健市場:產品變異分析
  • 按產品和收益
  • 疫苗
  • 藥品
  • 飼料添加劑
  • 診斷
  • 其他

第6章伴同性動物保健市場:通路、估計與趨勢分析

  • 全球伴同性動物保健市場:分銷通路儀表板
  • 全球伴同性動物保健市場:通路波動分析
  • 按分銷管道分類的收益
  • 零售
  • 電子商務
  • 醫院藥房

第7章伴同性動物保健市場:最終用途、估計和趨勢分析

  • 全球伴同性動物保健市場:最終用途儀表板
  • 全球伴同性動物保健市場:最終用途變化分析
  • 全球伴同性動物保健市場估計與預測最終用途、收益
  • 照護現場/內部測試
  • 醫院/診所
  • 其他

第8章伴同性動物保健市場:按區域、動物、產品、通路和最終用途的估計和趨勢分析

  • 區域儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第9章 競爭格局

  • 公司/競爭對手分類
  • 供應商情況
    • 2023年主要企業市場佔有率分析
  • 公司簡介
    • Agrolabo SpA
    • Boehringer Ingelheim International GmbH
    • Ceva
    • Elanco
    • IDEXX Laboratories, Inc.
    • Indian Immunologicals Ltd.
    • Merck &Co., Inc.
    • Norbrook
    • Vetoquinol
    • Virbac
    • Zoetis Services LLC
Product Code: GVR-2-68038-260-0

Companion Animal Health Market Growth & Trends:

The global companion animal health market size is expected to reach USD 42.50 billion by 2030, registering a CAGR of 9.3% over the forecast period, according to a new report by Grand View Research, Inc. The market is driven by rising research and development programs, growing numbers of government initiatives, increasing adoption of pets, and high volumes of veterinary surgeries & prevalence of chronic diseases in companion animals.The veterinary healthcare sector has experienced many challenges during the COVID-19 pandemic.Veterinarians could still work despite the shutdown. According to a survey of more than 3,000 pet owners in the U.S., UK, France, and Brazil, more than a quarter of pet owners have put off or avoided contacting their veterinarians since the pandemic started due to the fear of disease transmission.

Moreover, the majority of owners (65 percent) concur that the pandemic had no negative effects on access to medications and procedures.An increase in pet ownership is one of the major factors driving the market. Approximately 70% of households (90.5 million homes) in the U.S. have a pet, with dogs and cats being the most common breeds, according to the American Veterinary Medical Association. The market is also being driven by rising demand for pet medicine as more individuals own pets. The market for companion animal medication is also being driven by an increase in the demand for high-quality veterinarian care. Veterinary research and development activities have steadily increased during the last decade. There were numerous innovations in the fields of surgery and specialized medications for use in pets. To establish themselves as market leaders, major players are strategically integrating novel technologies.

For instance, in January 2022, the FDA approved Zoetis' first monoclonal antibody treatment for osteoarthritis, Solensia, which is intended to reduce pain in cats with the condition. Similar to this, the company has released Librela, a monoclonal antibody to lessen canine arthritic pain.In recent years, pet disease prevalence has increased in countries like France, which has increased the demand for pet treatment. Obesity, dental issues, skin allergies, osteoarthritis, and viral diseases are the most typical pet illnesses in France. The need for medications and preventive care to keep pets healthy and happy is highlighted by the rising prevalence of pet ailments in France. In addition, it is projected that the rising pharmaceutical and vaccine demand will further boost the market. The presence of government agencies that ensure the safety of veterinary pharmaceuticals, such as the French Agency for Veterinary Medicinal Products (ANMV), contributes to the growth of the market.

Companion Animal Health Market Report Highlights:

  • By product, the pharmaceuticals segment held a dominant share of over 44.43% in 2023. The introduction of medications to aid in extending animal lifespan has been accelerated by a notable rise in pet ownership
  • The dogs segment dominated the market with a share of over 40.0% in 2023 as a result of rising pet healthcare costs, particularly in developed regions
  • By distribution channel, the hospital pharmacies segment held the largest share of over 47% in 2023.The global availability of veterinary clinics and hospital services has increased due to the rising pet adoption rate
  • The hospitals & clinics end-use segment held a dominant share of over 80% in 2023. This is due to an expansion of veterinary hospitals and clinics with innovative infrastructure around the world. Another aspect influencing the segment growth is a rise in the number of veterinarians
  • North America held a 35.82% share of the overall market in 2023

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Animal
    • 1.2.2. Product
    • 1.2.3. Distribution Channel
    • 1.2.4. End-Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Animal Outlook
    • 2.2.2. Product Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. End-use Outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Companion Animal Health Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing pet ownership
      • 3.2.1.2. The rise of pet insurance
      • 3.2.1.3. Growing preference for personalized pet care
      • 3.2.1.4. Advancements in animal healthcare technology
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced veterinary treatments
      • 3.2.2.2. Increasing cost of animal testing and veterinary care
  • 3.3. Companion Animal Health Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
    • 3.3.3. Pipeline Analysis

Chapter 4. Companion Animal Health Market: Treatment Estimates & Trend Analysis

  • 4.1. Global Companion Animal Health Market: Animal Dashboard
  • 4.2. Global Companion Animal Health Market: Animal Movement Analysis
  • 4.3. Global Companion Animal Health Market by Animal, Revenue
  • 4.4. Dogs
    • 4.4.1. Dogs market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Equine
    • 4.5.1. Equine market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Cats
    • 4.6.1. Cats market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Companion Animal Health Market: Product Estimates & Trend Analysis

  • 5.1. Global Companion Animal Health Market: Product Dashboard
  • 5.2. Global Companion Animal Health Market: Product Movement Analysis
  • 5.3. Global Companion Animal Health Market Estimates and Forecasts, By Product, Revenue (USD Million)
  • 5.4. Vaccines
    • 5.4.1. Vaccines market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Pharmaceuticals
    • 5.5.1. Pharmaceuticals market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. OTC
      • 5.5.2.1. OTC market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. Prescription
      • 5.5.3.1. Prescription market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Feed Additives
    • 5.6.1. Feed Additives market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Diagnostics
    • 5.7.1. Diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Companion Animal Health Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Global Companion Animal Health Market: Distribution Channel Dashboard
  • 6.2. Global Companion Animal Health Market: Distribution Channel Movement Analysis
  • 6.3. Global Companion Animal Health Market Estimates and Forecasts by Distribution Channel, Revenue (USD Million)
  • 6.4. Retail
    • 6.4.1. Retail market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. E-commerce
    • 6.5.1. E-commerce market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Hospital pharmacies
    • 6.6.1. Hospital pharmacies market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Companion Animal Health Market: End -use Estimates & Trend Analysis

  • 7.1. Global Companion Animal Health Market: End-use Dashboard
  • 7.2. Global Companion Animal Health Market: End-use Movement Analysis
  • 7.3. Global Companion Animal Health Market Estimates and Forecasts End-use, Revenue (USD Million)
  • 7.4. Point-of-care/ In-house testing
    • 7.4.1. Point-of-care/ In-house testing estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Hospitals & clinics
    • 7.5.1. Hospitals & clinics market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Companion Animal Health Market: Regional Estimates & Trend Analysis by Animal, Product, Distribution Channel and End-use

  • 8.1. Regional Dashboard
  • 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.3. North America
    • 8.3.1. U.S.
      • 8.3.1.1. Key country dynamics
      • 8.3.1.2. Regulatory framework/ reimbursement structure
      • 8.3.1.3. Competitive scenario
      • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.2. Canada
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Regulatory framework/ reimbursement structure
      • 8.3.2.3. Competitive scenario
      • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.3.3. Mexico
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Regulatory framework/ reimbursement structure
      • 8.3.3.3. Competitive scenario
      • 8.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Key country dynamics
      • 8.4.1.2. Regulatory framework/ reimbursement structure
      • 8.4.1.3. Competitive scenario
      • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Regulatory framework/ reimbursement structure
      • 8.4.2.3. Competitive scenario
      • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.3. France
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Regulatory framework/ reimbursement structure
      • 8.4.3.3. Competitive scenario
      • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Regulatory framework/ reimbursement structure
      • 8.4.4.3. Competitive scenario
      • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Regulatory framework/ reimbursement structure
      • 8.4.5.3. Competitive scenario
      • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.6. Norway
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Regulatory framework/ reimbursement structure
      • 8.4.6.3. Competitive scenario
      • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Regulatory framework/ reimbursement structure
      • 8.4.7.3. Competitive scenario
      • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Regulatory framework/ reimbursement structure
      • 8.4.8.3. Competitive scenario
      • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Key country dynamics
      • 8.5.1.2. Regulatory framework/ reimbursement structure
      • 8.5.1.3. Competitive scenario
      • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Regulatory framework/ reimbursement structure
      • 8.5.2.3. Competitive scenario
      • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.3. India
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Regulatory framework/ reimbursement structure
      • 8.5.3.3. Competitive scenario
      • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Regulatory framework/ reimbursement structure
      • 8.5.4.3. Competitive scenario
      • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Regulatory framework/ reimbursement structure
      • 8.5.5.3. Competitive scenario
      • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.5.6. Thailand
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Regulatory framework/ reimbursement structure
      • 8.5.6.3. Competitive scenario
      • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Key country dynamics
      • 8.6.1.2. Regulatory framework/ reimbursement structure
      • 8.6.1.3. Competitive scenario
      • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.6.2. Argentina
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Regulatory framework/ reimbursement structure
      • 8.6.2.3. Competitive scenario
      • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Key country dynamics
      • 8.7.1.2. Regulatory framework/ reimbursement structure
      • 8.7.1.3. Competitive scenario
      • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Regulatory framework/ reimbursement structure
      • 8.7.2.3. Competitive scenario
      • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Regulatory framework/ reimbursement structure
      • 8.7.3.3. Competitive scenario
      • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Regulatory framework/ reimbursement structure
      • 8.7.4.3. Competitive scenario
      • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Vendor Landscape
    • 9.2.1. List of key distributors and channel partners
    • 9.2.2. Key customers
    • 9.2.3. Key company market share analysis, 2023
  • 9.3. Company Profile
    • 9.3.1. Agrolabo S.p.A
      • 9.3.1.1. Company overview
      • 9.3.1.2. Financial performance
      • 9.3.1.3. Product benchmarking
      • 9.3.1.4. Strategic initiatives
    • 9.3.2. Boehringer Ingelheim International GmbH
      • 9.3.2.1. Company overview
      • 9.3.2.2. Financial performance
      • 9.3.2.3. Product benchmarking
      • 9.3.2.4. Strategic initiatives
    • 9.3.3. Ceva
      • 9.3.3.1. Company overview
      • 9.3.3.2. Financial performance
      • 9.3.3.3. Product benchmarking
      • 9.3.3.4. Strategic initiatives
    • 9.3.4. Elanco
      • 9.3.4.1. Company overview
      • 9.3.4.2. Financial performance
      • 9.3.4.3. Product benchmarking
      • 9.3.4.4. Strategic initiatives
    • 9.3.5. IDEXX Laboratories, Inc.
      • 9.3.5.1. Company overview
      • 9.3.5.2. Financial performance
      • 9.3.5.3. Product benchmarking
      • 9.3.5.4. Strategic initiatives
    • 9.3.6. Indian Immunologicals Ltd.
      • 9.3.6.1. Company overview
      • 9.3.6.2. Financial performance
      • 9.3.6.3. Product benchmarking
      • 9.3.6.4. Strategic initiatives
    • 9.3.7. Merck & Co., Inc.
      • 9.3.7.1. Company overview
      • 9.3.7.2. Financial performance
      • 9.3.7.3. Product benchmarking
      • 9.3.7.4. Strategic initiatives
    • 9.3.8. Norbrook
      • 9.3.8.1. Company overview
      • 9.3.8.2. Financial performance
      • 9.3.8.3. Product benchmarking
      • 9.3.8.4. Strategic initiatives
    • 9.3.9. Vetoquinol
      • 9.3.9.1. Company overview
      • 9.3.9.2. Financial performance
      • 9.3.9.3. Product benchmarking
      • 9.3.9.4. Strategic initiatives
    • 9.3.10. Virbac
      • 9.3.10.1. Company overview
      • 9.3.10.2. Financial performance
      • 9.3.10.3. Product benchmarking
      • 9.3.10.4. Strategic initiatives
    • 9.3.11. Zoetis Services LLC
      • 9.3.11.1. Company overview
      • 9.3.11.2. Financial performance
      • 9.3.11.3. Product benchmarking
      • 9.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America companion animal health market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 4 North America companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 7 U.S companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 8 U.S companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 10 U.S companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 11 Canada companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 12 Canada companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 14 Canada companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 15 Mexico companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 16 Mexico companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 Mexico companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 19 Europe companion animal health market, by region, 2018 - 2030 (USD Million)
  • Table 20 Europe companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 21 Europe companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 22 Europe companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 23 Europe companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 24 Germany companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 25 Germany companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 26 Germany companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 27 Germany companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 28 UK companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 29 UK companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 30 UK companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 31 UK companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 32 France companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 33 France companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 34 France companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 35 France companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 36 Italy companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 37 Italy companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 38 Italy companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 Italy companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 40 Spain companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 41 Spain companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 42 Spain companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Spain companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 44 Denmark companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 45 Denmark companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 46 Denmark companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Denmark companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 48 Sweden companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 49 Sweden companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 50 Sweden companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 51 Sweden companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 52 Norway companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 53 Norway companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Norway companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific companion animal health market, by region, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 57 Asia Pacific companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 58 Asia Pacific companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 60 China companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 61 China companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 62 China companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 China companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 64 Japan companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 65 Japan companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 66 Japan companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67 Japan companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 68 India companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 69 India companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 70 India companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 India companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 72 South Korea companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 73 South Korea companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 74 South Korea companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75 South Korea companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 76 Australia companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 77 Australia companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 78 Australia companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79 Australia companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 80 Thailand companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 81 Thailand companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 82 Thailand companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 83 Thailand companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 84 Latin America companion animal health market, by region, 2018 - 2030 (USD Million)
  • Table 85 Latin America companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 86 Latin America companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 87 Latin America companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 88 Latin America companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 89 Brazil companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 90 Brazil companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 91 Brazil companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 92 Brazil companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 93 Argentina companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 94 Argentina companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 95 Argentina companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 96 Argentina companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 97 MEA companion animal health market, by region, 2018 - 2030 (USD Million)
  • Table 98 MEA companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 99 MEA companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 100 MEA companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 101 MEA companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 102 South Africa companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 103 South Africa companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 104 South Africa companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 105 South Africa companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 106 Saudi Arabia companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 110 UAE companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 111 UAE companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 112 UAE companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 113 UAE companion animal health market, by end - use, 2018 - 2030 (USD Million)
  • Table 114 Kuwait companion animal health market, by animal, 2018 - 2030 (USD Million)
  • Table 115 Kuwait companion animal health market, by product, 2018 - 2030 (USD Million)
  • Table 116 Kuwait companion animal health market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 117 Kuwait companion animal health market, by end - use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value - chain - based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Companion animal health market: market outlook
  • Fig. 14 Companion animal health competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Companion animal health market driver impact
  • Fig. 18 Companion animal health market restraint impact
  • Fig. 19 Companion animal health market: Animal movement analysis
  • Fig. 20 Companion animal health market: Animal outlook and key takeaways
  • Fig. 21 Dogs market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Equine market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Cats market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Companion animal health market: Product movement analysis
  • Fig. 26 Companion animal health market: Product outlook and key takeaways
  • Fig. 27 Vaccines market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 OTC market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Feed Additives market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Companion animal health market: Distribution Channel movement analysis
  • Fig. 35 Companion animal health market: Distribution Channel outlook and key takeaways
  • Fig. 36 Retail market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 E - commerce market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Companion animal health market: End - use movement analysis
  • Fig. 40 Companion animal health market: End - use outlook and key takeaways
  • Fig. 41 Point - of - care/In - house testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Hospitals & clinics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Global Companion animal health market: Regional movement analysis
  • Fig. 45 Global Companion Animal Health market: Regional outlook and key takeaways
  • Fig. 46 Global Companion Animal Health market share and leading players
  • Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 U.S key country dynamics
  • Fig. 49 U.S market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Canada key country dynamics
  • Fig. 51 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Mexico key country dynamics
  • Fig. 53 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UK key country dynamics
  • Fig. 56 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Germany key country dynamics
  • Fig. 58 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 France key country dynamics
  • Fig. 60 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Italy key country dynamics
  • Fig. 62 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Spain key country dynamics
  • Fig. 64 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Denmark key country dynamics
  • Fig. 66 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Sweden key country dynamics
  • Fig. 68 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Norway key country dynamics
  • Fig. 70 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 China key country dynamics
  • Fig. 73 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Japan key country dynamics
  • Fig. 75 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 India key country dynamics
  • Fig. 77 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Thailand key country dynamics
  • Fig. 79 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 South Korea key country dynamics
  • Fig. 81 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Australia key country dynamics
  • Fig. 83 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Brazil key country dynamics
  • Fig. 86 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina key country dynamics
  • Fig. 88 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 90 South Africa key country dynamics
  • Fig. 91 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 Saudi Arabia key country dynamics
  • Fig. 93 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 94 UAE key country dynamics
  • Fig. 95 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 96 Kuwait key country dynamics
  • Fig. 97 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Market share of key market players - companion animal health market